TerraBioGen Technologies Inc.
TSX VENTURE : TBG

TerraBioGen Technologies Inc.

July 04, 2011 10:18 ET

TerraBioGen Schedules Trials at Langara Golf Course

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 4, 2011) - TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of proprietary technologies for the production of organic-based, high-value agricultural products from organic wastes, is pleased to announce that it has scheduled growing trials at Langara Golf Course in Vancouver.

For several years, TerraBioGen has conducted product field trials on turf applications with leading institutes such as Cornell University's Department of Horticulture in Ithaca, New York, which generated very positive results. The Cornell study demonstrated that the use of TerraBioGen's products allowed up to a 50% reduction in synthetic fertilizer applications and up to a 75% reduction in pesticides without impacting turf quality. Highly successful commercial field trials have simultaneously been conducted at Nicklaus North Golf Course in Whistler, B.C. The field trial planned for Langara Golf Course in Vancouver coincides with proposed legislation before the provincial government that would ban the use of cosmetic pesticides in British Columbia.

Blair Heffelfinger, President and CEO of TerraBioGen stated "These growing trials are very important and have produced excellent results in the past by promoting turf quality, suppressing foliar and soil borne disease, and reducing synthetic fertilizer input requirements. We are pleased to play a role in the potential ban on cosmetic pesticides by providing an effective, safe, organically-based alternative."

Jeff MacLean, the Golf Course Superintendent at Langara commented "I am happy to be working with TerraBioGen once again. The results of our field trials at Nicklaus North were very encouraging, and these organic products could be a great fit with the City of Vancouver's commitment to a greener, more sustainable city. "

About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology and the quality of its agricultural products. It is further committed to developing a worldwide marketing capability to ensure market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information